Impact of the 340B Pharmacy Program on Services and Supports for Persons Served by Hemophilia Treatment Centers in the United States

Purpose Hemophilia Treatment Centers (HTCs) provide integrated and comprehensive services to individuals affected with rare bleeding disorders, such as hemophilia and Von Willebrand disease. Through the 340 Drug Pricing Program, HTCs may use pharmacy income to support clinical staff and patient serv...

Descripción completa

Detalles Bibliográficos
Autores principales: Malouin, Rebecca A., Mckernan, Laurel, Forsberg, Ann, Cheng, Dunlei, Drake, John, McLaughlin, Kathryn, Trujillo, Marisela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
From the Field
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096501/
https://www.ncbi.nlm.nih.gov/pubmed/29948762
http://dx.doi.org/10.1007/s10995-018-2545-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096501/
https://www.ncbi.nlm.nih.gov/pubmed/29948762
http://dx.doi.org/10.1007/s10995-018-2545-7

Ejemplares similares